No Easy Remedy For Roche - Wall Street Journal (blog)
Posted by admin / Under Diabetes UK
No Easy Remedy For Roche Wall Street Journal (blog) But development of experimental rheumatoid arthritis drug ocrelizumab had to be discontinued, the filing of diabetes drug candidate taspoglutide had to be ... |
Published on Friday 3rd of September 2010 09:25:47 AM





Share this!